mRNA Drug Market Size, Share, Growth, and Industry Analysis, By Type (Preventive Vaccines,Therapeutic Vaccine,Therapeutic Drugs), By Application (Hospital,Clinic), Regional Insights and Forecast to 2035

1 mRNA Drug Market Overview
1.1 Product Overview and Scope of mRNA Drug
1.2 mRNA Drug Segment by Type
1.2.1 Global mRNA Drug Market Value Comparison by Type (2023-2029)
1.2.2 Preventive Vaccines
1.2.3 Therapeutic Vaccine
1.2.4 Therapeutic Drugs
1.3 mRNA Drug Segment by Application
1.3.1 Global mRNA Drug Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global mRNA Drug Market Size Estimates and Forecasts
1.4.1 Global mRNA Drug Revenue 2018-2029
1.4.2 Global mRNA Drug Sales 2018-2029
1.4.3 Global mRNA Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 mRNA Drug Market Competition by Manufacturers
2.1 Global mRNA Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global mRNA Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global mRNA Drug Average Price by Manufacturers (2018-2023)
2.4 Global mRNA Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Drug, Product Type & Application
2.7 mRNA Drug Market Competitive Situation and Trends
2.7.1 mRNA Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest mRNA Drug Players Market Share by Revenue
2.7.3 Global mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 mRNA Drug Retrospective Market Scenario by Region
3.1 Global mRNA Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global mRNA Drug Global mRNA Drug Sales by Region: 2018-2029
3.2.1 Global mRNA Drug Sales by Region: 2018-2023
3.2.2 Global mRNA Drug Sales by Region: 2024-2029
3.3 Global mRNA Drug Global mRNA Drug Revenue by Region: 2018-2029
3.3.1 Global mRNA Drug Revenue by Region: 2018-2023
3.3.2 Global mRNA Drug Revenue by Region: 2024-2029
3.4 North America mRNA Drug Market Facts & Figures by Country
3.4.1 North America mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America mRNA Drug Sales by Country (2018-2029)
3.4.3 North America mRNA Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Drug Market Facts & Figures by Country
3.5.1 Europe mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe mRNA Drug Sales by Country (2018-2029)
3.5.3 Europe mRNA Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Drug Market Facts & Figures by Country
3.6.1 Asia Pacific mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific mRNA Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific mRNA Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Drug Market Facts & Figures by Country
3.7.1 Latin America mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America mRNA Drug Sales by Country (2018-2029)
3.7.3 Latin America mRNA Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa mRNA Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa mRNA Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa mRNA Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global mRNA Drug Sales by Type (2018-2029)
4.1.1 Global mRNA Drug Sales by Type (2018-2023)
4.1.2 Global mRNA Drug Sales by Type (2024-2029)
4.1.3 Global mRNA Drug Sales Market Share by Type (2018-2029)
4.2 Global mRNA Drug Revenue by Type (2018-2029)
4.2.1 Global mRNA Drug Revenue by Type (2018-2023)
4.2.2 Global mRNA Drug Revenue by Type (2024-2029)
4.2.3 Global mRNA Drug Revenue Market Share by Type (2018-2029)
4.3 Global mRNA Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global mRNA Drug Sales by Application (2018-2029)
5.1.1 Global mRNA Drug Sales by Application (2018-2023)
5.1.2 Global mRNA Drug Sales by Application (2024-2029)
5.1.3 Global mRNA Drug Sales Market Share by Application (2018-2029)
5.2 Global mRNA Drug Revenue by Application (2018-2029)
5.2.1 Global mRNA Drug Revenue by Application (2018-2023)
5.2.2 Global mRNA Drug Revenue by Application (2024-2029)
5.2.3 Global mRNA Drug Revenue Market Share by Application (2018-2029)
5.3 Global mRNA Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Moderna mRNA Drug Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer mRNA Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Zydus Cadila
6.3.1 Zydus Cadila Corporation Information
6.3.2 Zydus Cadila Description and Business Overview
6.3.3 Zydus Cadila mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zydus Cadila mRNA Drug Product Portfolio
6.3.5 Zydus Cadila Recent Developments/Updates
6.4 Fosun Pharma
6.4.1 Fosun Pharma Corporation Information
6.4.2 Fosun Pharma Description and Business Overview
6.4.3 Fosun Pharma mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fosun Pharma mRNA Drug Product Portfolio
6.4.5 Fosun Pharma Recent Developments/Updates
6.5 CureVAC
6.5.1 CureVAC Corporation Information
6.5.2 CureVAC Description and Business Overview
6.5.3 CureVAC mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CureVAC mRNA Drug Product Portfolio
6.5.5 CureVAC Recent Developments/Updates
6.6 Sri Lankan Microorganisms
6.6.1 Sri Lankan Microorganisms Corporation Information
6.6.2 Sri Lankan Microorganisms Description and Business Overview
6.6.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sri Lankan Microorganisms mRNA Drug Product Portfolio
6.6.5 Sri Lankan Microorganisms Recent Developments/Updates
6.7 BioNtech
6.6.1 BioNtech Corporation Information
6.6.2 BioNtech Description and Business Overview
6.6.3 BioNtech mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BioNtech mRNA Drug Product Portfolio
6.7.5 BioNtech Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca mRNA Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Janssen
6.9.1 Janssen Corporation Information
6.9.2 Janssen Description and Business Overview
6.9.3 Janssen mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Janssen mRNA Drug Product Portfolio
6.9.5 Janssen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Drug Industry Chain Analysis
7.2 mRNA Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Drug Production Mode & Process
7.4 mRNA Drug Sales and Marketing
7.4.1 mRNA Drug Sales Channels
7.4.2 mRNA Drug Distributors
7.5 mRNA Drug Customers
8 mRNA Drug Market Dynamics
8.1 mRNA Drug Industry Trends
8.2 mRNA Drug Market Drivers
8.3 mRNA Drug Market Challenges
8.4 mRNA Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer